CCA
EXAS

Childress Capital Advisors’s Exact Sciences EXAS Stock Holding History

Childress Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-63
Closed -$9K – 429
2020
Q4 		$9K Buy
+63
New +$7.62K 0.01% 576

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Childress Capital Advisors's EXAS Position: Q1 2021 in Review

Childress Capital Advisors sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 63 shares — an estimated $9K sold.

Childress Capital Advisors first reported a position in EXAS in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Childress Capital Advisors reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
  • Childress Capital Advisors sold 63 Exact Sciences shares in Q1 2021, an estimated $9K.
  • Childress Capital Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 1 quarter.
  • Childress Capital Advisors's Exact Sciences position peaked at $9K in Q4 2020.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.